|
Biogen Idec ( BIIB) Stock PriceCompany Description : Biogen Idec Inc is a biotechnology company which develops, manufactures & markets therapies, focusing on neurology, oncology, and immunology for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders. url: www.biogenidec.com |
Name:
Biogen Idec Inc. (MM) |
Symbol:
NASDAQ:BIIB |
Stock Market:
NASDAQ |
Type:
Common Stock |
ISIN:
US09062X1037 |
Description:
|
| | Change | Change % | Cur | Bid | Ask | High | Low | Open | Volume | Time | A | |  | 0.68 | 0.52 | 132.26 | 128.34 | 135.4 | 132.74 | 131.31 | 132.2 | 1479512 | 20:00:00 | | |
The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Bristol-Myers Squibb, Teva Pharmaceutical, Biogen Idec & Elan - ..
For Immediate Release Chicago, IL – May 21, 2012 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Dr. Reddy’s Laboratories... Biogen Idec News & Message Board Discussion
| Latest Biogen Idec News Headlines | | Date | Time | Source | | | 05/21/2012 | 4:30AM | ZACKS | The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Bristol-Myers Squibb, Teva Pharmaceutical, Biogen Idec & Elan - .. |
| 05/18/2012 | 11:41AM | ZACKS | Data on Elan & Biogen's Tysabri - Analyst Blog |
| 05/18/2012 | 9:31AM | PRNUS | Critical Alerts For Qualcomm, Simon Property, Silver Wheaton, Biogen Idec, and Nu Skin Released By InvestorsObserver |
| 05/17/2012 | 3:40PM | BW | New Analysis of Risk Stratification for TYSABRI® Published in New England Journal of Medicine |
| 05/14/2012 | 6:00PM | DJN | WSJ BLOG/Health: New Caution Urged Over Sole Oral MS Drug On the Market |
| 05/14/2012 | 1:09PM | DJN | UPDATE: FDA Concludes Safety Review Of Novartis MS Drug Gilenya |
| 05/14/2012 | 8:00AM | BW | New AVONEX® Dosing Innovations for People with Multiple Sclerosis Now Available in US |
| 05/14/2012 | 4:30AM | ZACKS | Zacks Bull and Bear of the Day Highlights: Eastman Chemical, Kirkland's, Biogen Idec, Abbott, Novartis - Press Releases |
| 05/11/2012 | 11:00AM | ZACKS | Standard Review for Biogen's BG-12 - Analyst Blog |
| 05/09/2012 | 4:05PM | BW | US and EU Regulatory Authorities Accept Oral BG-12 Marketing Applications for Review |
| 05/09/2012 | 8:00AM | ZACKS | Isis Loss Widens on Higher Expenses - Analyst Blog |
| 05/08/2012 | 8:45AM | ZACKS | Earnings Beat at PDL BioPharma - Analyst Blog |
| |
Biogen Idec Company Information| Sector | Turnover (m) | Profit (m) | EPS - Basic | PE ratio | Mkt Cap (m) | NMS | | | 0.00 | 0.00 | | | 0.0 | N/A |
 Register for FREE access to the latest Biogen Idec company information and fundamental data for other USA Common Stock companies. More than 100 separate statistics including assets turnover and market capitalisation. |
Latest Biogen Idec Stock Trade| Type | Size | Price | Date | Tr.Time | Units | | | 183 | 0.0001 | 05/21/2012 | 10:25PM | USD |
|
|
| |